Meta-analysis and dose-response metaregression: Circulating Insulin-Like Growth Factor I (IGF-I) and mortality

Anne Marij G Burgers, Nienke R. Biermasz, Jan W. Schoones, Alberto M. Pereira, Andrew G. Renehan, Marcel Zwahlen, Matthias Egger, Olaf M. Dekkers

    Research output: Contribution to journalArticlepeer-review


    Context: IGF-I playsacentral role in metabolismandgrowthregulation.HighIGF- I levels are associated with increased cancer risk and low IGF-I levels with increased risk for cardiovascular disease. Objective: Our objective was to determine the relationship between circulating IGF-I levels and mortality in the general population using random-effects meta-analysis and dose-response metaregression. Data Sources: We searched PubMed, EMBASE, Web of Science, and Cochrane Library from 1985 to September 2010 to identify relevant studies. Study Selection: Population-based cohort studies and (nested) case-control studies reporting on the relation between circulating IGF-I and mortality were assessed for eligibility. Data Extraction: Data extraction was performed by two investigators independently, using a standardized data extraction sheet. Data Synthesis: Twelve studies, with 14,906 participants, were included. Overall, risk of bias was limited. Mortality in subjects with low or high IGF-I levels was compared with mid-centile reference categories. All-cause mortality was increased in subjects with low as well as high IGF-I, with a hazard ratio(HR)of1.27(95%CI=1.08-1.49)andHRof1.18(95%CI = 1.04-1.34), respectively.Dose-response metaregression showed a U-shaped relation of IGF-I and all-cause mortality (P = 0.003). The predicted HR for the increase in mortality comparing the 10th IGF-I with the 50th percentile was 1.56 (95% CI = 1.31-1.86); the predicted HR comparing the 90th with the 50th percentile was 1.29 (95% CI = 1.06-1.58). A U-shaped relationship was present for both cancer mortality and cardiovascular mortality. Conclusions: Both low and high IGF-I concentrations are associated with increased mortality in the general population. Copyright © 2011 by The Endocrine Society.
    Original languageEnglish
    Pages (from-to)2912-2920
    Number of pages8
    JournalJournal of Clinical Endocrinology and Metabolism
    Issue number9
    Publication statusPublished - Sept 2011


    Dive into the research topics of 'Meta-analysis and dose-response metaregression: Circulating Insulin-Like Growth Factor I (IGF-I) and mortality'. Together they form a unique fingerprint.

    Cite this